1、#. A Study of Ethnic Differences in TGFβ1 Gene Polymorphisms and Effects on the Risk of Radiation Pneumonitis in Non-Small-Cell Lung Cancer. . J Thorac Oncol. 2012 Nov;7(11):1668-75.,;
2、#. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients. . J Surg Oncol. 2012 Jun 18. doi: 10.1002/jso.23190.,;
3、#. Long-term survival in thymic epithelial tumors: A single-center experience from China. . J Surg Oncol. 2012 Sep 20. doi: 10.1002/jso.23256.,;
4、#. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines. . Lung Cancer. 2012,;
5、#. Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment.. Chinese Medical Journal 2011;124(15):2279-2283,;
6、#. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case–control studies. . Mutagenesis (2011) (doi: 10.1093/ mutage/ ger002), March 14, 2011,;
7、#. Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells. . Cell Biochem Funct. 2011 Mar;29(2):142-8,;
8、#. Discrepancy of biologic behavior influenced by bone marrow derived cells in lung cancer.. ONCOLOGY REPORTS，2010;24(5):1185-92,;
9、#. A Cost-Effectiveness Analysis of Docetaxel versus Pemetrexedin Second-line Chemotherapy for Stage III b or IV Non-Small Cell Lung Cancer Patients in China.. CHEMOTHERAPY,2010,56（6）：472-477.,;
10、#. Chinese Pediatric and Adolescent Primary Tracheobronchial Tumors:a Hospital- Based Study.. Pediatric Surgery International,2011,Feb,online (DOI:10.1007/s00383-011-2858-8),;
11、#. Third-Line Therapy for Advanced Non-Small-Cell Lung Cancer Patients: Feasible Drugs for Feasible Patients. . Medical Oncology,2010,Dec,online,;
12、#. Functional roles of PC-PLC and Cdc20 in the cell cycle,proliferation, and apoptosis.. Cell Biochem Funct. 2010,28(4), P 249 – 257,;
|
